Yesterday I attended LSPN’s spring North America meeting, and what a stimulating and valuable event it was.  Gathered together was a...

When is a product "protected" by a basic patent for the purpose of Article 3(a) of the SPC Regulation? This question has kept the courts...

In a speech to mark World IP Day, the British Government's IP Minister, Sam Gyimah, announced that the UK has ratified the Agreement on a...

The patent system exists to encourage and reward innovation. It does this by preventing people from copying others’ innovative ideas, in...

This time last week I had the privilege of attending the 5th Biennial Biosimilars and Biobetters Congress in London. The conference...

Last month, we reported on the curious case of lower-league football team Dulwich Hamlet Football Club and the somewhat bizarre decision...

It was a privilege to attend the 5th Annual Peptides Congress in London yesterday and interact with so many experts in this field. Here...

Today we are exhibiting at the 5th Biennial Biosimilars and Biobetters Congress in London. 

It is great to be part of an event that...

Most often, the invention in a patent application is for early stage, sometimes speculative, research which is yet to be fully realised....

I’m really looking forward to next week’s Biosimilars and Biobetters Congress in London. The organisers have put together a high-powered...

Following the release of the annual statistics from the European Patent Office (EPO), the World Intellectual Property Organisation (WIPO)

Antibody technology has advanced a long way since the early days of Kohler & Milstein’s antibody-secreting murine hybridomas. Whilst...

Most countries have patent laws which prohibit − directly or indirectly − the patenting of immoral inventions. However, the concept of...

Every now and then a story pops up in the papers in which a large company is accused of using its trade mark rights to bully a smaller...